This report provides industry leaders and investors interested in the European markets a realistic estimate of its current market sizes and a detailed analysis of the countries where the most opportunities exist. What it will not provide is long-term, uncertain projections with no basis in data.
In 2018, only three countries—Germany, Italy and the Netherlands—had meaningful sales of medical cannabis in Europe. Many other countries showed positive signs, advancing with legislation that either allowed national production or prescription, but those markets are far from established.
The immediate opportunities in Europe consist of:
This report covers:
Access the full article from Marijuana Business Daily International here: https://mjbizdaily.com/wp-content/uploads/2019/04/Medical-Cannabis-in-Europe-Report_FINAL_REV2.pdf